Hutch News

Hutch News

Stories tagged 'Diseases'

Dr. Kevin Cheung receives prestigious ‘Era of Hope’ Scholar Award

$4.1 million, four-year award to advance understanding of breast cancer metastasis

Feb. 22, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch’s Dr. Kevin Cheung, a metastatic breast cancer researcher, has received a $4.1M Department of Defense Breast Cancer Research Program “Era of Hope” Scholar Award.

View story >


Lobular breast cancer comes into the spotlight

Research collaborations, patient advocates push to explore ‘sneaky,’ understudied subtype’s standing as a distinct disease

Feb. 15, 2018 | By Diane Mapes / Fred Hutch News Service

Lobular breast cancer is the sixth most common cancer in women yet many people have never heard of it. It doesn't image well, may not create a lump and is considered to be an "understudied" cancer. That's changing. Fred Hutch researchers and patient advocates break it down.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 25, 2018

Dr. Goldie Lui receives grant from Ovarian Cancer Research Fund Alliance; Fred Hutch, SCCA receive ‘Good Neighbor’ and ‘Nonprofit of the Year’ awards from South Lake Union Chamber.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Jan. 18, 2018

Metastatic breast cancer researchers receive postdoc scholarships; Hutch receives three state CARE Fund grants for cancer research; HemOnc Today names Dr. Damian Green a Next Gen Innovator.

View story >


Remembering Dr. Eddie Méndez

Hutch friends and colleagues recall brilliant physician-scientist and ‘bright, shining star’

Jan. 11, 2018 | By Sabrina Richards / Fred Hutch News Service

Remembering Dr. Eddie Mendez, brilliant surgeon and researcher dedicated to helping patients with head-and-neck cancer.

View story >


Could a prostate cancer drug save lives from radiation injury?

Early research shows potential for approved hormone-blocking drug to protect from deadly effects of nuclear blast

Jan. 9, 2018 | By Susan Keown / Fred Hutch News Service

A new study used a hormone-blocking prostate cancer drug called degarelix to save the lives of mice exposed to a deadly level of radiation. Could it do the same for people caught in a nuclear blast?

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.